The role of PTPN22 in autoimmunity: Learning from mice

Autoimmunity Reviews

Volumn 13, Issue 3, 2014, Pages 266-271

  Zheng, Junfeng ^a   Petersen, Frank ^b   Yu, Xinhua ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Autoimmune diseases; Autoimmunity; Protein tyrosine phosphatase nonreceptor 22; Susceptibility gene

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; INNATE IMMUNITY; LEARNING; MACROPHAGE; NONHUMAN; REVIEW; T LYMPHOCYTE;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; C-SRC TYROSINE; CSK; DC; DENDRITIC CELL; GC; GERMINAL CENTERS; INTERFERON REGULATORY FACTOR 3; IRF3; LYMPHOID TYROSINE PHOSPHATASE; LYP; PEP; PEST DOMAIN-ENRICHED TYROSINE; PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22; PTPN22; RA; REGULATORY T CELLS; RHEUMATOID ARTHRITIS; SLE; SUSCEPTIBILITY GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL RECEPTOR; T1D; TCR; TLR; TNF RECEPTOR-ASSOCIATED FACTOR 3; TOLL LIKE RECEPTORS; TRAF3; TREG; TYPE 1 DIABETES; TYPE 1 IFN; TYPE 1 INTERFERONS;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; IMMUNITY, INNATE; MICE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84891744142     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.10.011     Document Type: Review

References (45)

1. Begovich A.B.., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet Aug 2004, 75(2):330-337.
2. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet Apr 2004, 36(4):337-338.
3. Kyogoku C., Langefeld C.D., Ortmann W.A., Lee A., Selby S., Carlton V.E., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet Sep 2004, 75(3):504-507.
4. Zheng J., Ibrahim S., Petersen F., Yu X. Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue. Genes Immun Dec 2012, 13(8):641-652.
5. Cohen S., Dadi H., Shaoul E., Sharfe N., Roifman C.M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase. Lyp Blood Mar 15 1999, 93(6):2013-2024.
6. Brownlie R.J., Miosge L.A., Vassilakos D., Svensson L.M., Cope A., Zamoyska R. Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function. Sci Signal Nov 27 2012, 5(252):ra87.
7. Hasegawa K., Martin F., Huang G., Tumas D., Diehl L., Chan A.C. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science Jan 30 2004, 303(5658):685-689.
8. Dai X., James R.G., Habib T., Singh S., Jackson S., Khim S., et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest May 1 2013, 123(5):2024-2036.
9. Zhang J., Zahir N., Jiang Q., Miliotis H., Heyraud S., Meng X., et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet Sep 2011, 43(9):902-907.
10. Zheng P., Kissler S. PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant. Diabetes Mar 2013, 62(3):896-904.
11. Yeh L.T., Miaw S.C., Lin M.H., Chou F.C., Shieh S.J., Chuang Y.P., et al. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice. J Immunol Jul 15 2013, 191(2):594-607.
12. Bygrave A.E., Rose K.L., Cortes-Hernandez J., Warren J., Rigby R.J., Cook H.T., et al. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol Aug 2004, 2(8):E243.
13. Zikherman J., Hermiston M., Steiner D., Hasegawa K., Chan A., Weiss A. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J Immunol Apr 1 2009, 182(7):4093-4106.
14. Josefowicz S.Z., Lu L.F., Rudensky A.Y. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012, 30:531-564.
15. Langier S., Sade K., Kivity S. Regulatory T cells: the suppressor arm of the immune system. Autoimmun Rev Dec 2010, 10(2):112-115.
16. Maine C.J., Hamilton-Williams E.E., Cheung J., Stanford S.M., Bottini N., Wicker L.S., et al. PTPN22 alters the development of regulatory T cells in the thymus. J Immunol Jun 1 2012, 188(11):5267-5275.
17. Chang H.H., Miaw S.C., Tseng W., Sun Y.W., Liu C.C., Tsao H.W., et al. PTPN22 modulates macrophage polarization and susceptibility to dextran sulfate sodium-induced colitis. J Immunol Sep 1 2013, 191(5):2134-2143.
18. Wang Y., Shaked I., Stanford S.M., Zhou W., Curtsinger J.M., Mikulski Z., et al. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity Jul 25 2013, 39(1):111-122.
19. Cloutier J.F., Veillette A. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J Sep 16 1996, 15(18):4909-4918.
20. Cloutier J.F., Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999 Jan 4, 189(1):111-121.
21. Matthews R.J., Bowne D.B., Flores E., Thomas M.L. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol May 1992, 12(5):2396-2405.
22. Gjorloff-Wingren A., Saxena M., Williams S., Hammi D., Mustelin T. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur J Immunol Dec 1999, 29(12):3845-3854.
23. Gianchecchi E., Palombi M., Fierabracci A. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity. Autoimmun Rev May 2013, 12(7):717-725.
24. Rieck M., Arechiga A., Onengut-Gumuscu S., Greenbaum C., Concannon P., Buckner J.H. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol Oct 1 2007, 179(7):4704-4710.
25. Menard L., Saadoun D., Isnardi I., Ng Y.S., Meyers G., Massad C., et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest Sep 2011, 121(9):3635-3644.
26. Aarnisalo J., Treszl A., Svec P., Marttila J., Oling V., Simell O., et al. Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J Autoimmun Aug 2008, 31(1):13-21.
27. Arechiga A.F., Habib T., He Y., Zhang X., Zhang Z.Y., Funk A., et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol Mar 15 2009, 182(6):3343-3347.
28. Fiorillo E., Orru V., Stanford S.M., Liu Y., Salek M., Rapini N., et al. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J Biol Chem Aug 20 2010, 285(34):26506-26518.
29. Vang T., Congia M., Macis M.D., Musumeci L., Orru V., Zavattari P., et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet Dec 2005, 37(12):1317-1319.
30. Vang T., Liu W.H., Delacroix L., Wu S., Vasile S., Dahl R., et al. LYP inhibits T-cell activation when dissociated from CSK. Nat Chem Biol May 2012, 8(5):437-446.
31. Lefvert A.K., Zhao Y., Ramanujam R., Yu S., Pirskanen R., Hammarstrom L. PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis. J Neuroimmunol Jul 15 2008, 197(2):110-113.
32. Bolland S., Ravetch J.V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity Aug 2000, 13(2):277-285.
33. Miyamoto A., Nakayama K., Imaki H., Hirose S., Jiang Y., Abe M., et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature Apr 25 2002, 416(6883):865-869.
34. O'Keefe T.L., Williams G.T., Davies S.L., Neuberger M.S. Hyperresponsive B cells in CD22-deficient mice. Science Nov 1 1996, 274(5288):798-801.
35. Luzina I.G., Atamas S.P., Storrer C.E., daSilva L.C., Kelsoe G., Papadimitriou J.C., et al. Spontaneous formation of germinal centers in autoimmune mice. J Leukoc Biol Oct 2001, 70(4):578-584.
36. az-Gallo L.M., Gourh P., Broen J., Simeon C., Fonollosa V., Ortego-Centeno N., et al. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis Mar 2011, 70(3):454-462.
37. Reveille J.D. The genetic basis of autoantibody production. Autoimmun Rev Jul 2006, 5(6):389-398.
38. Gregersen P.K. Gaining insight into PTPN22 and autoimmunity. Nat Genet Dec 2005, 37(12):1300-1302.
39. Stanford S.M., Rapini N., Bottini N. Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity. Immunology Sep 2012, 137(1):1-19.
40. Hall J.C., Rosen A. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol Jan 2010, 6(1):40-49.
41. Sansonno L., Tucci F.A., Sansonno S., Lauletta G., Troiani L., Sansonno D. B cells and HCV: an infection model of autoimmunity. Autoimmun Rev Dec 2009, 9(2):93-94.
42. Temajo N.O., Howard N. The viral enterprises in autoimmunity: conversion of target cells into de novo APCs is the presage to autoimmunity. Autoimmun Rev Jul 2012, 11(9):653-658.
43. Wu S., Bottini M., Rickert R.C., Mustelin T., Tautz L. In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation. ChemMedChem Mar 2009, 4(3):440-444.
44. Yu X., Sun J.P., He Y., Guo X., Liu S., Zhou B., et al. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Proc Natl Acad Sci U S A Dec 11 2007, 104(50):19767-19772.
45. Chapman S.J., Khor C.C., Vannberg F.O., Maskell N.A., Davies C.W., Hedley E.L., et al. PTPN22 and invasive bacterial disease. Nat Genet May 2006, 38(5):499-500.